Dredging Collaterals and Glucose-regulating Category—Jinlida Granules
May 19,2023 | YILING
- National Varieties for Medical Insurance Drugs
- National Key New Product
- High-tech Product designated by the Ministry of Science and Technology of the P.R.C
- National Protected Varieties of Traditional Chinese Medicine.
- It is reported that Type-2 diabetes has become a major threat to human health. There are 113.9 million patients with diabetes in adults over 18 years old and about 493.4 million people with pre-diabetes in China. Jinlida Granules has definite curative effect in regulating glucose and lipid metabolism, improving glucose tolerance, reducing insulin resistance and decreasing complications.
Clinical evidence-based study on metformin combined with Jinlida Granules in the treatment of Type-2 diabetes
Leading Hospital: Guang'anmen Hospital, China Academy of Chinese Medical Science (CACMS)
Cooperating Hospitals: Xiyuan Hospital of China Academy of Chinese Medical Science (CACMS), Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Shanxi Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Shanxi University of Traditional Chinese Medicine, Bethune International Peace Hospital, etc.
On the basis of diet control, exercise therapy and stable dose of metformin, combined application of Jinlida Granules can better control the glycosylated hemoglobin in patients with Type-2 diabetes. The Jinlida Granules group had potential therapeutic advantages in reducing waist circumference reducing complications, and improving the functions of islet β - cells.
Ginseng Radix et Rhizoma, Polygonati Rhizoma, Atractyloadis Rhizoma (stir- baked with bran), Sophorae Flavescentis Radix, Ophiopogonis
Radix, Rehmanniae Radix, Polygoni Multiflori Radix Praeparata, Corni Fructus, Poria, Eupatorii Herba, Coptidis Rhizoma, Anemarrhenae
Rhizoma, Epimedii Folium (processed), Salviae Miltiorrhizae Radix et Rhizoma, Puerariae Thomsonii Radix, Litchi Semen, Lycii Cortex.
Reduce the HOMA IR index, improve insulin resistance.
Combined with metformin can further reduce HbA1c in 0.92%.
Regulate lipid metabolism, improve insulin resistance, and reduce patients’ micro albuminuria and carotid intima-media thickness
【Dosage】Take medicine after infusing with hot water, 1 sachet/
time, 3 times/day. 8 weeks for a course of treatment, or follow the
【Packing】Compound membrane sachet, 9 sachets/box,
【MA Number】 License of State Drug Administration Z20050845